ArticleHeliyon2024

Small intestinal metastasis in a lung adenocarcinoma patient with concurrent EML4-ALK V3 and TP53 mutations after distinct responses to tyrosine kinase inhibitors: A case report.

Lingling Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.